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ABSTRACT

Protein coding regions of the PrPC gene in 51 pigs belonging to 3 breeds namely
Hampshire, Yorkshire, Blue Butt Cross (blue spotted cross from a Hampshire X
Yorkshire), and a wild pig were studied. These breeds are used nationwide for
commercial purposes. The PrPC gene of the pigs that code for prion proteins were
sequenced and studied. Deletions of the octapeptide (WGQPHGGG) were observed in 13
samples that belongs to the crossbreed Dark Cross sow 71 by Blue Butt Boar (Gummy
bear). This hydrophobic repeat has been used in experiments as a model to investigate
neurodegeneration in prion diseases. Also, it was used as vaccine where the octapeptide
sequence was administered in a liposomal bilayer and when administered to an animal,
the vaccine elicited a local or systemic, immunogen-specific immune response against
amyloid proteins, peptides or fragments. In previous studies, prion proteins commonly
have five or six repeats, while in this study, four octarepeats were obtained in all samples
except the few that contained only three octarepeats. The presence of the octapeptide is
said to be correlated with increased susceptibility of prion disease. If this is the case,
these individuals may be less susceptible to prion disease as compared to other breeds.
Still, research needs to be done to confirm this. Those sequences were then compared
with the PrPC genes of other mammals. Based on these sequences, a phylogenetic tree
was constructed. Also, the gender of the pigs does not seem to play role in whether the
octapeptide deletion occurs.
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PREFACE
This thesis follows the style of American Society for Microbiology.
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INTRODUCTION

Prion diseases
Prion diseases are neurodegenerative disorders caused by the pathogenic isoform
of a normal constituent of cell membrane called prion protein (Johnson 2005). These
diseases are collectively called transmissible spongiform encephalopathies (TSEs) and are
named differently depending on the species they infect, and includes Kuru and
Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in
cows, scrapie in sheep, and chronic wasting disease (CWD) in deer and elk (Choi et al.
2012).
Prion disease leads to impairment of brain function, decline in intellectual
function, and abnormal movements (National Institutes of Health 2014). About 10 -15%
of the cases of human prion diseases are the result of mutations in the PrPC gene, while
the remaining 85-90% are classified as either sporadic or acquired.
Sporadic prion disease does not have a genetic predisposition or an identified
mutation in the PrPC gene and occurs when the normal prion protein (PrPC) is transformed
to an abnormal sporadic form of prion protein (PrPSC) (Figure 1). The mechanism for this
transformation is yet unknown, but prion diseases are transmitted by consumption of
infected feed or by contact with infected animals (Johnson 2005). The sporadic form of
human prion disease includes sporadic CJD (sCJD), sporadic fatal insomnia (sFI), and
variably protease-sensitive prionopathy (VPSPr). On the other hand, acquired prion
disease is caused by the exposure to PrPSC from an external source, as in vCJD, BSE, and
Kuru. In some cases, prion disease is caused through accidental exposure to PrPSC during
1

a medical procedure. This method of transmission is classified as iatrogenic (National
Institutes of Health 2014).

History of prion research
The historical background of prion disease dates back to 1700, when a disease
‘scrapie’ was first reported in sheep (Hunter 1993) but it did not receive public attention
until the 1980s. Scrapie once was thought to be caused by sexual overactivity. It was then
considered to be a viral disease. Broad scale research and production of several
hypotheses occurred rapidly after reports that the scrapie from sheep was transmitted to
mice (Morris and Gajdusek 1963) and from goats to mice (Chandler 1961, Chandler
1963). Hunter (1993) showed that scrapie passed through an ultrafilter of 30 nm and was
highly hydrophobic. He concluded its replication did not depend on intrinsic nucleic acid.
Kuru, a type of TSE, was first identified in humans as a strange encephalitis-like disease
in the Fore tribe of Papua New Guinea. A young virologist, D. Carlton Gajdusek and his
team were working to isolate a virus but all attempts were in vain (Gajdusek and Gibbs
1964). They concluded cannibalism, a culture followed in Papua New Guinea, to be the
vehicle of kuru transmission, but the causative organism or substance was still unknown
(Liberski et al. 2012). Later, William Hadlow recognized a micrograph of kuru pathology
to be reminiscent of scrapie, and kuru was finally identified as a type of TSE (Farquhar
and Gajdusek 1981). Other TSE related diseases have their own history of identification
and prevalence.
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Stanley B. Prusiner (1982), forwarded the idea that prion disease is caused by
protein and nothing else. Unlike other diseases, including viral diseases, prion disease
does not follow the basic principles of the central dogma of molecular biology, which
holds that diseases that are transmissible contain genetic material like DNA or RNA.
Hence, he gave the term ‘prion’ to the protein, which was to be pronounced as ‘pree-on’
and derived from two words ‘protenacious’ and ‘infection’ (Prusiner 1982). Prion protein
then changes its structure to an abnormal form, causing disease. He, along with other
researchers, then concluded that abnormal prion protein converts normal prion protein to
abnormal form and this process occurs rapidly (Prusiner 1995)
BSE was first discovered in Great Britain in 1986. The neuropathology of BSE
was similar to that of scrapie in sheep, and so, the disease was recognized as a spongiform
encephalopathy. Afterwards several cases of BSE were reported that resulted in epidemics
among cows. Epidemiological studies revealed that meat-and-bone-meal (MBM) might be
used as a vehicle to transfer the disease. Hence in June 1988, the U.K. government banned
the use of ruminant-derived MBM to be fed to ruminants, but it was still allowed to be
feed to pigs and poultry, as these animals were not thought to be susceptible to BSE.
Several other cases occurred even after the ban, which gave rise to a new hypothesis that
pigs and poultry might act as carriers and cross-contaminate the infected feeds. After the
first case of vCJD was reported in 1996, feeding mammalian protein to any cattle was
banned. After this ban in 1996, the BSE cases declined from 44,000 in 1992 to 57 after
1996 (Smith and Bradley 2003). vCJD, which was thought to be acquired in people by
consuming BSE contaminated beef, had some similarities with the previously known
3

human prion disease CJD (Ingram 2013). Also, during the same decade when BSE
outbreak in cattle and the vCJD outbreak in people, Feline Spongiform Encephalopathy
(FSE) was confirmed in domestic cats in Great Britain as the result of eating pet food
made with BSE. By the end of 1999, the number of cases of FSE recorded reached 87
(World Health Organization, 1999).
Prion protein overall structure:
The widespread distribution of prion protein among mammals prompted
biologists to determine its structure. Three-dimensional structure and functional
properties of the proteins were then compared with nucleotide and amino acid sequences
(Calzolai et al. 2005). Due to the low yield of the purified prion protein in previous work,
it was difficult obtain structural results using NMR spectroscopy or X-ray
crystallography. So, recombinant PrPC was developed to study the protein structure,
which suggested that recombinant PrPSC contains three alpha helices and one small antiparallel beta sheet (Acevedo-Morantes and Wille 2014).
Based on NMR measurements, conformation of recombinant human PrPC was
determined (Hosszu et al. 1999) as shown in Figure 2. It consists of a signal peptide, and
with the addition of glycophosphatidylinisitol (GPI) anchor functions as a membrane
attachment signal. PrPC is further made up of a flexible N- terminal domain and a largely
helical C- terminal domain. The N-terminal domain is involved in the regulation of
copper and zinc whereas the C-terminal domain is involved in the conversion of alpha
helix to beta sheets during the development of prion disease. Both of these domains are
independent of one another and do not interact (Stockel et al. 1998). The C-terminus
4

forms a globular domain, comprising three alpha helices and a short double stranded beta
sheet, stabilized by a disulfide bond. The domain contains two N-linked glycosylation
sites (Rheede et al. 2003). Similarly, conformations of PrPC of hamster (James et al.
1997), bovine (Garcia et al. 2000), mouse (Riek et al. 1996, 1997), and others were also
determined using NMR. Globular folds of all these mammals were highly similar
(Rheede et al. 2003). This globular domain is highly conserved among various species, as
the nucleotide sequences of different species encoding this globular domain are almost
identical. (Dominikus et al. 2005). A study based on NMR structures has shown the pig
prion protein has a single charge-effective amino acid substitution in the position 223
relative to cow prion protein. In addition, amino acid replacement from Asn-173 in the
cow prion protein to Ser-173 in pigs is found to stabilize the 100-173 loop in the protein
due to its neutral charge. It is hypothesized that this extra stability may explain why
naturally occurring prion diseases have not been reported in pigs. The study thus has
presumed that this substitution might affect the protein structure (Prusiner 1998). Change
in the conformation of normal PrPC to abnormal PrPSC is carried out by the increase in
beta-sheet content from 3% to around 40%, whereas alpha-helix content is decreased
from 40% to 30% (Cohen and Prusiner 1998).

Prion protein octarepeat region
Physiological function of prion protein explains how membrane-bound prion
protein binds to copper in the N- terminal domain (Whittal et al. 2000). The octarepeat
region in the N- terminal domain has been observed in residues 60-91 in PrPC of humans
and other mammals, including pig, syrian hamster, and others. The prion protein in these
5

animals consists of four or more repeats of the residue sequence PHGGGWGQ. Those
humans who contain extra octarepeats in their prion protein are prone to CreutzfeldtJakob disease (Goldfarb et al. 1991). Similarly, in an experiment done in mice, removal of
the octarepeat domain helped in the slowing the progression of disease (Flechsig et al.
2000). Also, when copper was added to wild prion protein, protease resistance was
favored, which is a characteristic feature of the pathogenic form (Quaglio et al. 2001). The
cellular membrane prion protein (PrPC) is GPI-anchored, which exists on the membrane
surface (Vey et al. 1996), where exchange of divalent copper occurs (Pen᷈a et al. 1999,
Waggoner et al. 2000). The above mentioned octarepeat peptide domain binds four Cu2+
ions with significant cooperativity as compared to other divalent metal ions (Whittal et al.
2000). Circular dichroism (CD) studies have indicated that coordination in PHGGGWGQ
and HGGG peptides develops from the imidazole ring of histidine amino acid and three
amide nitrogen within HGGG unit (Bonomo et al. 2000). These studies suggested
fundamental ideas on the functions of PrPC as a copper sensor as well as transporter, and
also the role of octarepeat in transmembrane signaling leading to the copper-mediated
conversion of PrPC to PrPSC (Burns et al. 2002).
The octapeptide repeat (OR) region is a highly conserved part of PrPC in
mammals (Harris et al. 1991). The 92-111 region is denoted as a non-OR region which is
adjacent to the hydrophobic residues (112-127), and contains two additional His residues
and which are also hypothesized to play a part in the prion conversion. A high degree of
conservation is observed in the residues 90 to 127 among different mammals. Because the
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OR region does not seem to be play a role in the conversion of prion to the abnormal
form, the non-OR copper binding site is being studied currently.
The non- OR copper binding site is found to be adjacent to the palindromic amino
acid motif sequence AGAAAAGA. This palindromic motif is involved in causing the
structural changes during the initial prion converting phase. A recent study has also shown
that the interaction among copper and peptide, including both palindromic motif and nonOR residues induce beta-sheet formation, which results in the aggregation of the peptide
segment (Giachin et al. 2015).

Species barriers
Though PrPC sequence is highly conserved among mammals, prions are not
observed to transfer easily from one species to another (Collinge 2012). Slight
polymorphisms in the amino acids might play a major role in the transmission efficiency
(Beringue et al. 2008). For example, in the case of sheep, homozygosity for the
V136R154Q171 (VRQ) allele has shown high susceptibility to classical scrapie whereas
homozygosity in allele A136R154Q171 (ARQ) exhibits major resistance (Belt et al. 1995,
Goldmann et al. 2016). In the same way, human susceptibility to TSE is influenced by the
amino acid polymorphism at residue 129 (Collinge 2001, Wadsworth and Collinge 2007).
Transmission of the TSE agent within the species was noted first in sheep scrapie in the
1930’s (Belt et al. 1995). Cross species transmission of prion is less common than
intraspecies transmission. The emergence of new vCJD strain in humans, after the BSE
outbreak, has demonstrated the ability of prion disease to be transferred from one species
7

to the other. Conformational flexibility of the prion protein, along with the ability to
infect foreign hosts, seems to play an important role in strain variation, but this is a
complex process, which is difficult to comprehend (Beringue et al. 2008).
Previous studies explained that the difference in the primary structure of protein
between host and donor species is the major point where the species barrier resides. In an
experiment by Scott et al. (1989), hamster PrPC was expressed in transgenic mice, which
developed susceptibility to hamster scrapie (Kimberlin and Walker 1978) which resulted
in the apparent lack of species barrier. Here, the PrPC gene of host and infecting species
were identical. In this way, mice transgenic lines were developed for sheep (Crozet et al.
2001, Vilotte et al. 2001, and Westaway et al. 1994), bovine (Beringue et al. 2006,
Buschmann and Groschup 2005), human (Asante et al. 2002), and other mammals. Also,
transgenic lines have been made by using gene replacement method. In this work, a series
of inbred lines of transgenic mice were produced and PrPC genes were expressed in each,
which allowed the study of the direct influence of the host PrPC gene in TSEs. Hence,
these experiments gave the conclusion that identity in the PrPC sequence among
transgenic host and donor leads to the increased susceptibility to TSE when compared to
the wild type mice (Cancellotti et al. 2007).
Hence, interspecies transmission of prions results in varying outcomes based on
the type of species. For example, some species can show resistance to infection, while
some might possess asymptomatic disease which might act like a carrier and can pass
disease to a different species more easily. Also, certain species can show permanent or
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reversible change of strain properties, and some might show faithful propagation
(Beringue et al. 2008).
Past studies with the recombinant prion protein PrPC have explained prion
assembly as a nucleation-dependent polymerization process, which also gives different
insight into the species barrier concept. In these studies, fibrils were made of bacteriallyexpressed PrPC in such a way that those were able to polymerize into amyloid fibrils
either spontaneously or by adding preformed fibrils(Surewicz et al. 2006, Noinville et al.
2008). In the study done by Surewicz et al. (2006), recombinant PrPC fibrils were
generated using mouse, human or hamster PrPC. They were morphologically different to
one another. Also, experiments were carried out to examine the cross-seeding capacities
of the fibrils which concluded that mouse monomers could be converted by hamster fibril
seeds, whereas the opposite could not happen. Once formed, the mouse fibril generated
from the hamster can then polymerize the hamster PrPC monomers into fibrils. These
newly formed hamster PrPC fibrils adopted different secondary structure as compared to
that of mouse fibrils generated by mouse PrPC monomers. This study has also explained
that point mutations can influence the seeding barrier by changing the conformation of
amyloid fibrils with mutant fibrils and adopting PrPC of a different species. For example,
in case of human variant PrPC, mutation at position 138 and 139 where isoleucine is
replaced by methionine, the seeding capacity is affected, which is similar to that seen in
the hamster protein. It resulted in the hamster- like fibril conformation (Jones and
Surewicz 2005, Vanik et al. 2004).
Risk of prion zoonoses
9

Transmission of prion disease from cattle to human is a major concern to public
health. There is evidence of clinical disease in the transgenic mouse expressing human
PrPC protein which were exposed to BSE prions (Beringue et al. 2012), whereas prion
infection in spleen was observed in high proportion and infection in brain was seen in
less than 10% of mice kept for longer incubation periods. Prions might not be harmful by
the subclinical infection caused from foreign prions, but when they adapt to new host
species, high lethality was obtained in the individuals of that species (Hill et al. 2000).
This is important in terms of public health because humans colonized with silent vCJD
prions can transfer prions to healthy individuals via blood transfusion, tissue donation,
and other contamination during surgery (Weissmann 2002). In 1996, vCJD was found in
a human caused by exposure to BSE strain (Collinge 2001). But the rate of vCJD
transmission was very low which might be the result of the species barrier. Research has
shown that during BSE outbreak, rate of vCJD was 1 in 4000 of UK population.
(Spongiform Encephalopathy Advisory Committee position statement, 2008).

Prions in pigs
Naturally occurring prion diseases have not yet been identified in pigs (Sus
scrofa). As pigs were clearly exposed to the ruminant derived meal during the British BSE
epidemic, studies were conducted to examine if BSE was transmitted to them. But BSE
was not found to be transmitted from feeding infected brain materials to pigs, while BSE
was observed in animals when brain homogenate from BSE infected cows was inoculated
to healthy pigs through intracerebral, intravenous, and intraperitoneal routes (Gibbs et al.
10

1979). Study of prion proteins in pigs is important because they are widely used in human
daily life. More than one billion pigs are consumed by humans every year. Although
natural TSEs have not yet been identified in pigs, there is a possibility these prion-diseaseresistant pigs can be carriers of replicating prions (Hammarstrom and Nystrom 2015).
Since pigs are also considered to be excellent organ donors for humans, because humans
and pigs share similar physiology, there is another possibility that prion disease could be
transmitted to humans during xenotransplantation (Meng et al. 2005).

Purpose of my research
Based on species barrier, transmission of PrPSC, and to develop therapeutic
interventions, the basic goal of all prion related research is to have knowledge and
understanding of the structure and function of prion protein regions that are involved in
the generation and aggregation of PrPSC. In this research, my objective was to sequence
the prion encoding gene extracted from pig tissues (Figure 3) and look for polymorphisms
in the sequences. The aim of this study was to see if the polymorphisms in the sequences
have contributed to changes in copper binding domain of the prion protein along with
studying if these have links to species diversity. Subsequently, the sequences were
compared with other prion disease susceptible and non-susceptible mammals. Because
pigs live in close proximity to humans and though there are no naturally reported pig prion
disease, research on pig prion protein should be given prior importance and should be
continued.
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MATERIALS AND METHODS

Sample collection:
A total of 51 samples were sampled, 50 from domestic piglets collected from Fort
Hays State University farm belonging to 3 breeds, namely Hampshire, Yorkshire, Blue
Butt Cross (blue spotted cross from a Hampshire X Yorkshire), and 1 from a wild pig.
Table 1 shows a list of 50 samples taken from the FHSU farm. These breeds are used
nationwide for commercial purposes. Out of 50 domestic pigs, 23 were female and 27
were male. The pigs’ tails had been docked and placed in 70% ethanol and stored in 20°C freezer until DNA extraction.
Genomic DNA isolation:
Total genomic DNA was isolated from each sample using the extraction kit from
Qiagen (Hilden, Germany) as per the instruction from manufacturer and eluted in 50 µl of
nuclease-free water. Before starting extracting procedure, samples were washed with
double-distilled water. The extracted DNA was visualized in 1% agarose gel to verify the
DNA was non-degraded. Furthermore, the quality and quantity of DNA was measured
using a spectrophotometer (Nanodrop Technologies, Wilmington, DE).

Polymerase Chain Reaction:
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Polymerase Chain Reaction (PCR) was used to detect the presence of PrPC genes
in samples of isolated genomic DNA. Primer sequences from Martin et al. (1995),
obtained from Sigma, were used in PCR reactions.
The forward primer was Por PrP fwd 5’CATTTGATGCTGACACCCTCTTTA3’ and
reverse primer was Por Prp rev 5’ATGAGACACCACCACTACAGGGCT3’. DNA was
amplified using Phusion Polymerase kit obtained from Biolabs Inc. (Ipswich, MA).
Annealing temperature was identified as 60 oC which did not match with the one used by
Martin et al. (1995).
Amplification of selected regions was carried out in 50 µL of reaction mixture.
PCR components were combined in 0.5 mL micro centrifuge tube as follows: 10 µL of
5X Phusion High Fidelity Buffer, 2.5 µL of 10 µM PrP forward primer, 2.5 µL of 10 µM
reverse primer, 1 µL of 10 mM dNTPs, 0.5 µL Phusion polymerase, 2 µL of template
DNA, and 31.5 µL of nuclease-free water. The optimized PCR conditions were 98 oC for
30 seconds, followed by 30 cycles of 98 oC for 10 seconds, 60 oC for 30 seconds, and 72
o

C for 30 seconds. The final elongation was occurred at72 oC for 10 minutes.

Agarose gel electrophoresis, PCR purification, and sequencing
The qualitative assessment and quantitative estimation of amplicons generated by
PCR was verified by gel electrophoresis using Tris-acetate-EDTA in 1% agarose gels
(Agarose low EEO, Thermo Fisher Scientific, Waltham, MA) and stained with Sybersafe
obtained from Invitrogen (Carlsbad, CA). The one Kb DNA ladder, obtained from
Promega, (Madison, WI), was used in the gel and the loading dye used was from
13

GelPilot. Correct amplicons were purified using QIAquick PCR purification kit (Qiagen,
Hilden, Germany) following manufacturer’s instructions and eluted in nuclease-free
water. Each sample having a concentration of around 30 ng/L was then sequenced at the
Sequencing and Genotyping Facility of Kansas State University (Manhattan, KS) using a
3730 DNA Analyzer (Applied Biosystems, Foster City, CA) and Genewiz (South
Plainfield, NJ).

Sequence alignment and data analysis:
From the nucleotide sequences, protein accession, nucleotide accession, gene
annotation, and full length protein sequences were obtained using National Center for
Biotechnological Information (NCBI). Based on the sequence of pig prion protein
obtained from NCBI, sequences of all 51pig prion proteins were compared and
polymorphisms were identified. Nucleotide sequences were aligned in Clustal Omega
(Version 1.2.1, Thompson et al. 1994) and BioEdit Sequence Alignment Editor (Version
7.2.5, Hall 1999).

Phylogenetic tree construction
Prion sequences of other mammals were retrieved from NCBI GenBank;
Cricetulus griseus (Chinese hamster), Canis familiaris (dog), Bos taurus (cow), Felis
catus (cat), Ovis aries (sheep), Homo sapiens (humans), and Cervus Nippon (sika deer)
and analyzed with the sequences obtained from pig samples. A phylogenetic tree based
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on Maximum Likelihood method was constructed using mega software (Version 7. 0. 18,
Kumar et al. 2016).
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RESULTS

PrPC Gene Detection by PCR
The PCR assay demonstrated the presence of the PrPC gene in all 51 samples,
including domestic and wild pigs (Figure 4). Based on the sequences obtained from the
DNA Sequencing and Genotyping Facility at Kansas State University and Genewiz, the
nucleotide sequences of length 774 base pairs were obtained and those sequences were
translated into amino acid sequences of length 257. A few multiple peaks of nucleotides
were obtained in samples 23-1, 23-4, 24-1, and 24-7.Sequence was not obtained for
sample 23-5.
Polymorphisms in the PrPC gene
Four octapeptide repeats (PHGGGWGQ) were observed in all the samples based
on the aligned translated protein sequences of PrPC gene. But in samples, 9-1, 9-2, 9-4, 95, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and 23-10, eight amino acids WGQPHGGG
or one complete octapeptide repeat domain were deleted (Figure 5 and 6). These samples
with missing amino acids belong to the same pig cross, namely ‘Dark Cross sow 71 by
Blue Butt Boar (Gummy bear)’. The octapeptide repeat was conserved in all other
samples from domestic pigs as well as the wild pig. The octapeptide repeat region was
followed by 21 non-octapeptide repeats, after which an alanine rich palindromic amino
acid motif sequence AGAAAAGA was observed in all the samples, including other
mammals. Hydrophobic amino acids were found in a row, starting immediately following
16

the palindromic sequence AGAAAGA. Polymorphism was not observed to be related
with the gender of the pigs. Both male and female pigs had presence and absence of the
octapeptide deletion.
Phylogenetic tree
A molecular phylogenetic tree was obtained using Maximum Likelihood method
with Mega 7 software. All gaps and missing data were eliminated and an unrooted
analysis was performed. The branch length signifies the rate of nucleotide substitutions.
In the tree obtained, branch lengths of most of the pig samples were equal due to almost
identical sequences. Branch lengths of rest of the pig samples and other mammals are
shown in Figure 7. Rest of the mammals appeared in a different clade.
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DISCUSSION

The deletion of one octapeptide as observed in the crossbreed samples 9-1, 9-2, 94, 9-5, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and 23-10 can be the result of mutated
PrPC. Such mutation might result in the mutation of the PrPC protein (Acevedo-Morantes
and Wille 2014). Experiments conducted previously have shown that the octapeptide
repeat mutation might result in genetic prion disease in humans. Insertion of additional
octapeptide repeats makes an individual more prone towards the prion disease and thus
the degree of prion aggregation was found to be proportional to the number of
octapeptide repeats present. The increased octapeptide repeats resulting in increased
aggregation can be the result of inheritance of mutated octapeptide repeat sequence (Yu
2007). The wild pig sample used in this study did not show any deletion of octapeptides,
which might suggest that wild pigs have the same prion susceptibility to prion disease as
that of domestic pigs.
The octapeptide repeat motif PHGGGWGQ (Figure 5 and 6), observed in the Nterminal domain of the PrPC protein has a high affinity for copper ions (Cu2+) and other
divalent cations such as zinc in specific pH conditions. Copper binding plays an
important role in converting alpha helix to a beta sheet structure. The above mentioned
13 samples with one octapeptide deletion in each, contain only three octapeptide repeats
which might have reduced the copper binding domain from two to one, since two
octapeptide repeats bind to one Cu2+ ion (Stockel et al. 1998). This might contribute to
fewer possibility of converting an alpha helix to a beta sheet. This can be one of the
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reasons behind why the crossbreeds Dark Cross sow 71 by Blue Butt Boar (Gummy
Bear) might be less susceptible to prion disease than the rest of the pig breeds. Research
has shown that one Cu2+ ion binds to two octapeptides and the imidazole side chain of the
histidine present in the octapeptides acts as a chelating ligand. NMR spectroscopy has
demonstrated that in the absence of copper ions, octapeptide repeats fail to achieve
secondary or tertiary structure. (Stockel et al. 1998). Recent research has suggested that
zinc binds to octapeptide and the C-terminal domain via electrostatic interaction which
contributes in the tertiary structure contact. This contact then further results to the
familial prion disease (Spevacek 2013). In the mice without prion protein, or with
infectious prion protein, copper and iron metabolism is abnormal (Brown 2003).
AGAAAAGA, is the hydrophobic core of the protein and is the N-terminal
palindrome of PrPC. It was present in all 51 samples sequenced and is shown in Figure 5
and 6. This is a highly conserved sequence motif found in most of the mammals studied
so far (Acevedo-Morantes and Wille 2014). Norstrom and Mastrianni (2005) suggested
that this AGAAAAGA palindrome is required for obtaining the PrPSC conformation.
Mutants without the palindromic sequence were unable to convert PrPC to PrPSC. Also,
the palindromic motif was found to facilitate the association of PrPC with PrPSC,which
results in the aggregation of abnormal protein (Norstrom and Mastrianni 2005).
The deleted sequences WGQPHGGG as seen in pigs of crossbreed Dark Cross
sow 71 by Blue Butt Boar (Gummy bear) was noted to be used as vaccine against prion
disease. In the past, Nicolau and Kapetanovic (2004) had worked on the vaccine against
prion diseases. They used different segments of prion protein as a vaccine, including the
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deleted sequences WGQPHGGG, where it is administered in a liposomal bilayer. When
administered to an animal, the vaccine elicits a local or systemic, immunogen-specific
immune response against amyloid proteins, peptides or fragments, and prevents, stops or
hinders amyloid deposition caused by prions. Traditional vaccines, made from either
purified antigens or the attenuated form of pathogen, which illicit the immune responses
in the individual did not work for prion disease. This might be because it is molecular
structure of the abnormal prion protein not the nucleic acid sequences, that is involved in
causing prion disease (Nicolau and Kapetanovic 2004).
The phylogenetic tree (Figure 7) shows the evolutionary history of the prion
proteins. Branch lengths of most of the pig samples was equal due to almost identical
sequences and the remaining samples, which were seen in a different clade, are those
having octapeptide deletion . The sequences of mammals subjected for phylogeny
analyses were chosen in such a way that both prion susceptible mammals like cow, sheep,
cat, human, and prion non-susceptible mammals like dog and pig are included for study.
Taking into consideration that both pigs and dogs do not easily get prion disease, their
phylogeny was expected to be closely related, but result was not obtained as expected.
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CONCLUSION

In the samples 9-1, 9-2, 9-4, 9-5, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and
23-10, eight amino acids WGQPHGGG were deleted. All these samples with deletions
are from the same breed (Dark cross sow 71 by Blue butt boar). From the observed
results, and based on the research done by Stockel et al. (1998), we can hypothesize that
the Dark Cross sow 71 by Blue Butt Boar (Gummy Bear) crosses might be less
susceptible to prion disease as these crosses have one less octapeptide repeat as compared
to rest of the domestic breeds and wild pig. Because two octapeptide repeats bind to one
Cu2+ ion, there will be one less octapeptide repeat in these breeds that can bind Cu2+ ion,
which might contribute to lower possibility of conversion of alpha helix to beta sheets.
The result might also indicate that wild pig’s prion susceptibility is similar to that of the
domestic pigs having four octapeptide repeats and wild pigs might have been separated
from the herd of domestic pigs in the course of time. This study might be valuable if this
possibility is investigated in future animal studies. Differences in the susceptibility might
be observed when the prion disease infected brain material is injected in the brain of
these pigs. Those pigs with one less octapeptide repeat might show disease at a lower rate
as compared to the others with four octapeptide repeats. Also, the gender of the pigs does
not seem to play role in disease susceptibility.
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Sample No.

Individual Crosses

9-1 to 9-11

Dark Cross sow 71 by Blue Butt Boar (Gummy bear)

10-1 to 10-7

Pure York sow by Blue Butt Boar (Gummy bear)

19-1 to 19-7

Pure Duroc sow by Berkshire Boar

22-1 to 22-5

Pure York sow by Blue Butt Boar (Gummy bear)

23-1 to 23-10 Dark Cross sow 71 by Blue Butt Boar (Gummy bear)
24-1 to 24-10 Dark Cross (Half Hampshire by Half Duroc) bred by Blue Butt Boar
(Gummy bear)

Table 1. Overview of DNA samples used in the study of polymorphism in the PrPc prion
protein gene in pigs.
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Normal

Diseased prlon

Figure 1. Normal and abnormal form of prion protein. Normal prion protein has amino
acids in alpha helix with less than 5% of beta sheets. Abnormal prion protein is a
misfolded protein, where majority of alpha helices are converted into beta sheets resulting
in more than 50% of beta sheets. (Source: Mayo Foundation of Medical Education and
Research). Accessed on: 3/16/2017
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Figure 2. Organization of human PrPC. The PrPC, having 253 amino acid residues,
contains one signal peptide (1-22), four octapeptide repeats (113-135), one hydrophobic
region (113-135), two N-linked glycosylation sites (181 and 197 residues), and one
glycophosphatidylinositol-anchor signal (232-254). Mutated prion protein contains up to
nine additional octapeptide repeats or deletion of one octapeptide. The palindromic amino
acid motif AGAAAAGA lies in the hydrophobic region. (Source: Acevedo-Morantes and
Wille 2014)
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Figure 3. Piglets of approximately 10 days old at Fort Hays State University farm. 23
female and 27 male pigs were studied.Tails of the piglets are docked a few days after
their birth so they do not hurt each other.
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10000 bp
3000 bp

1000 bp

Figure 4. Electrophoresis gel picture of amplified PCR fragment of PrPC gene obtained
from the pigs at Fort Hays State University farm. Lane 1: 1 Kb ladder (Promega). Lane 210: PCR amplicons of sample 9-1 to 9-9.
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Four octarepeats (PHGGGWGQ)

Palindromic amino acid motif (AGAAAAGA)

9-1
9-2

9-4
9-5
9-6
9-7
9-8
9-9

9-11

Figure 5: Deletion of octapeptide WGQPHGGG observed during multiple alignment of
PrPC prion protein in pig samples 9-1, 9-2, 9-4, 9-5, 9-6, 9-7, 9-8, 9-9, and 9-11. All
these samples with deletions are from the same breed (Dark cross sow 71 by Blue butt
boar) ‘Dashes‘ represent Deleted amino acid, ‘Asterisks’ represent gaps. A- Alanine, GGlycine, V- Valine, K- Lysine, W- Tryptophan, Q- Glutamine, P- Proline, H- Histidine,
S- Serine, T- Threonine, and N- Asparagine.
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Four octarepeats (PHGGGWGQ)

Palindromic amino acid motif (AGAAAAGA)

23-6
23-7
23-8
23-10

Figure 6: Deletion of octapeptide WGQPHGGG observed during multiple alignment of
PrPC prion protein in pig samples 23-6, 23-7, 23-8, and 23-10. All these samples with
deletions are from the same breed (Dark cross sow 71 by Blue butt boar).
‘Dashes‘represent deleted amino acid, ‘Asterisks’ represent gaps. A- Alanine, GGlycine, V- Valine, K- Lysine, W- Tryptophan, Q- Glutamine, P- Proline, H- Histidine,
S- Serine, T- Threonine, and N- Asparagine.
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Figure 7. Phylogenetic tree derived from prion nucleotide sequences of pigs and few
other mammals.
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Appendix 1: Amino acid sequences
1.

Sus scrofa (GenBank)
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLISFLLFPPFXS

2.

9-1
MVXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS

3.

9-2
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRPKXGPV*SSXSSPPVILLXLFPPFXS

4.

9-3
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS

5.

9-4
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWRQGGGSRGR*SRPSNPKTNMKHVAGAAATGAVGGGLGGYMLGSAMSKP
LIHFGSDYEDRFYRENMYRYPNQMYYRPLDQFSNQNIFVHDCLNISVNHCTMTTTTKGENFTNTDVKNIDRVEXT
DVHHPVPTKVQGLLP-KXGPM*SSXSSAPVILFXLSPPVXS

6.

9-5
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRWR*SGPSHPKTNMNHVPGATANGAVGGGLGGDMLGGAMSNP
LVRFVSDYQDRFYRENKYRYPHQIFYRPLDQFYYQPIFVHDCLNISVHHCTMTTTTKGENSTTTDGEIINHVEXTD
EHHPVPTKVQGLLP-KXGPRRSSXSWPPVILFXLSPPDXS

7.

9-6
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRGR*SKPSNPKTNMKHVAGATATGAVGGGLGGYMLGSAMSNP
LIHFVSDYEDRFYRENMYRYPNQMYYRPLDQFNYQTIFVHDCLNISVHHCTVTTTTKGENFTNTDVKIIDRAEXT
DVHHPVPTKVRGVLP-KXRPMRSSXSSPPVILLXLSPPFXS

8.

9-7
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS

9.

9-8
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
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10. 9-9
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGC*RQGGGSRWRQSGASHPKTNMNHVPGTTANGAVGGGLGGYMLGGPMSNP
LVRFVSNYEDRFYRENKYRYPNQNFYRPPNQFNYQPIFVHDCLNISVHDCTMTTTTKGENSTNTDVKNINHTEXT
DDHHPVPTKVQGLLP-KXSPRRSSXSWATVILLXLSPRDXS
11. 9-10
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
12. 9-11
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRGR*SGASHRKTNMKHVPGATATGAVGGGLGGDMLGGAMSNP
LVRFVSDYQDRFYRENKYRYPNQNFYRPLNQFNYQPIFVHDCLNIFVHHCTMTTTTKGENSTNTDGKNIDHAEXT
DDHHPVATKVQGLLPKXGPMRSSXSWAPVILFXLSPPDXS
13. 10-1
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
14. 10-2
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
15. 10-3
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
16. 10-4
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
17. 10-5
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
18. 10-6
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
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19. 10-7
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
20. 19-1
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
21. 19-2
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPKXGPV*SSXSSPPVILLXLFPPFXS
22. 19-3
MXXKSXXGGWILVLXCGRME*HRXSAXSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
23. 19-4
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
24. 19-5
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
25. 19-6
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPXKXGPV*SSXSSPPVILLXLFPPFXS
26. 19-7
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
27. 22-1
MXXEXPIGGWVLVLXCGSME*HMXSSKSDQXLAEEGTLXXGAYTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPXKXGPV*SSXSSPPVILLXLFPPFXS
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28. 22-2
MXXKXXXGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
29. 22-3
MXXKIXIGGWILVLXCGRME*HRXSAKSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
30. 22-4
MXXENPIGGWILVLXCGSME*HMVSSQNDQXLAGEGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRXXKXGPV*SSXSSPPVILLXLFPPFXS
31. 22-5
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
32. 23-1
V*XKLHILCWILVLGRFRNXQWXVASYKKXPSLAW**TLXXGAYPXGRVDMEXNPYPPQGGGGWGHPQGGGG
GQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVGTDVHHPVPERVRGVRP-KEGPV*SSXSSPPVILLXLFPSFSS
33. 23-2
MXXKIXIGGWILVLXCGSME*HRXSAKSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
34. 23-3
XXXKTXXGGWILVLXCGRME*HRXSARSDXSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPEXVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
35. 23-4
VLXNLQVLLXXAXLGRYRNXQWXVRSYERXQXLAGW*SLXXGAWTLGRVVMEXNPFPPKGGGGWGHPQGGG
GGQPHIGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGS
AMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMI
ERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
36. 23-6
MXXESXIGGWILVLXCGRME*HRXSAKSDQXLAEEGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
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37. 23-7
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRWR*SGASHPKTNMKHVPGATATGAVGGGLGGYMLGGAMSNP
LVRFVSDYEDRFYREYKYRYSNQNFYRPLNQFYYQPIYVHDCLNIFVHHCTMTTTTKGENFTTTDGEIIDRAEXT
DEHHRVATKVQGVLP-KXGPMRSSXSSPPVILFXLSPRFXS
38. 23-8
MXKVSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGH*NKPSNPKTNMKHVAGAAATGAVGGGLGGYMLGSAMSK
PLIHFGSDYEDRFYRENMYRYPNQMYYRPLDQFSNQNIFVHDCVNISVKHCTVTTTTKGENFTNTDVKMIDRVV
XTDVHHPVPKRVQGVLP-KXSPM*SSXSSPPVILLILFPPFXS
39. 23-9
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
40. 23-10
MXXKVSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQ
PHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMS
RPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERV
VXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
41. 24-1
V*XKLEILYWXMEASDLWGSXQ*HITSYKKMQGLAGCGTLXXGAYTLGRVVLGXNPFPPQGGGGWGQPQGGG
WGQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
42. 24-2
XKXXQNPILGWVLVXXCGSXE*XXAS*KNEQXLAGEGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
43. 24-3
VXXTLHIRGPWTVVGGYHNPQLXVVDXGRX*YL*RWCSAXXGPWXXDWVLAKTRKGXPPMLSLG*GRPQGGG
GARRXIPCRGRASYGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSFSSPPVILLXLFPPFPS
44. 24-4
MXRNPIFGWILXIXWGNXQ*XRXSAKKEQGLAGGGTLXXGAYTQGRVVLEXNRFPPQGGGGWGQPHGGGWGQ
PHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMS
RPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERV
VXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
45. 24-5
VXXTLPIRGWILVLGGFSNRXWXLVS*KKXQXLAW**SLXXGAYPXGWVVMEXNRYPPKGGGGWGHPQGGGW
GQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS

47

46. 24-6
XTXRNPMFGMXSLXIXCGRXQ*HRXSAKNDQGLAGGGTLXXGAYTQGRVVLEXNRYPPQGGGGWGQPQGGG
WGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
47. 24-7
XPXXQILILGEXVLVLXFGNXE*XVVSYKNEQXLAGEGTLXXGAYTLGRVVMEXNRYPPQGGGGWGQPHGGG
WGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
48. 24-8
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
49. 24-9
MXXKIXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
50. 24-10
MXXKXXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS
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Appendix 2. Pig prion protein information
Nucleotide accession: L07623.1
Protein accession: AAA92862.1
Gene annotation: Sus scrofa prion protein (PrP) gene, complete cds
Coding sequence: 1-774 base pairs
Amino acid feature: Putative glycosylation sites, base pairs 185 and 201
Protein translation:
MVKSHIGGWILVLFVAAWSDIGLCKKRPKPGGGWNTGGSRYPGQGSPGGNRYP
PQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQ
WNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGSDYEDRYY
RENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDV
KMIERVVEQMCITQYQKEYEAYAQRGASVILFSSPPVILLISFLLFLIVG
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